- Company Directors - V
- Valente Louis P
Insider Trading History of Valente Louis P
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Valente Louis P since 2006.
The trader's CIK number is 1202744.
At the time of the last reporting, Valente Louis P was the Director of Mks Instruments Inc. (stock ticker symbol MKSI).
Also see all insider trading activities at Mks Instruments Inc.
Note that in the past
VALENTE LOUIS P also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Mks Instruments Inc (MKSI) by Valente Louis P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | MKSI | 0 | $0 | 2,000 | $63,476 | 0 | $0 |
| 2011 | MKSI | 0 | $0 | 48,000 | $1,271,628 | 48,000 | $927,840 |
| 2010 | MKSI | 0 | $0 | 2,000 | $48,060 | 0 | $0 |
| 2009 | MKSI | 0 | $0 | 20,500 | $319,975 | 16,500 | $233,400 |
| 2008 | MKSI | 0 | $0 | 4,000 | $96,480 | 4,000 | $0 |
| 2007 | MKSI | 0 | $0 | 1,810 | $50,417 | 0 | $0 |
Yearly summary of insider trading at Medical Information Technology, Inc. (N/A) by Valente Louis P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | N/A | 15,000 | $8,325,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Palomar Medical Technologies Inc (PMTI) by Valente Louis P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | PMTI | 0 | $0 | 0 | $0 | 6,667 | $53,135 |
| 2007 | PMTI | 0 | $0 | 3,901 | $214,555 | 0 | $0 |
| 2006 | PMTI | 0 | $0 | 89,512 | $4,740,984 | 63,333 | $683,363 |
Insider trading activities at 3 companies by Valente Louis P:
1. Mks Instruments Inc (MKSI)
2. Medical Information Technology, Inc. (N/A)
3. Palomar Medical Technologies Inc (PMTI)
Table 1. Insider trading of Mks Instruments Inc (MKSI) by Valente Louis P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-02-06 | MKSI | Sale | 2,000 | 31.74 | 63,476 |
| 2011-11-04 | MKSI | Option Ex | 12,000 | 24.35 | 292,200 |
| 2011-11-04 | MKSI | Sale | 12,000 | 27.27 | 327,204 |
| 2011-07-28 | MKSI | Option Ex | 12,000 | 20.07 | 240,840 |
| 2011-07-28 | MKSI | Sale | 12,000 | 25.13 | 301,608 |
| 2011-05-06 | MKSI | Option Ex | 24,000 | 16.45 | 394,800 |
| 2011-05-06 | MKSI | Sale | 24,000 | 26.78 | 642,816 |
| 2010-12-17 | MKSI | Sale | 2,000 | 24.03 | 48,060 |
| 2009-08-03 | MKSI | Sale | 4,000 | 19.60 | 78,400 |
| 2009-03-18 | MKSI | Option Ex | 10,500 | 14.00 | 147,000 |
| 2009-03-18 | MKSI | Sale | 10,500 | 14.35 | 150,675 |
| 2009-02-06 | MKSI | Option Ex | 6,000 | 14.40 | 86,400 |
| 2009-02-06 | MKSI | Sale | 6,000 | 15.15 | 90,900 |
| 2008-05-08 | MKSI | Sale | 4,000 | 24.12 | 96,480 |
| 2008-05-04 | MKSI | Option Ex | 4,000 | .00 | 0 |
| 2007-06-14 | MKSI | Sale | 1,810 | 27.86 | 50,417 |
Table 2. Insider trading of Medical Information Technology, Inc. (N/A) by Valente Louis P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-03-12 | N/A | Buy | 15,000 | 555,000.00 | 8,325,000,000 |
Table 3. Insider trading of Palomar Medical Technologies Inc (PMTI) by Valente Louis P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-08-16 | PMTI | Option Ex | 6,667 | 7.97 | 53,135 |
| 2007-02-07 | PMTI | Sale | 3,901 | 55.00 | 214,555 |
| 2006-12-26 | PMTI | Option Ex | 63,333 | 10.79 | 683,363 |
| 2006-12-13 | PMTI | Sale | 13,000 | 52.10 | 677,365 |
| 2006-12-14 | PMTI | Sale | 35,000 | 53.11 | 1,858,710 |
| 2006-12-15 | PMTI | Sale | 41,512 | 53.12 | 2,204,909 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Valente Louis P
(Director of Mks Instruments Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.